Review Note
Last Update: 01/29/2024 05:13 PM
Current Deck: Grenko Pharm Drugs 2024
Published
Fields:
Text
Dimenhydrinate: {{c1::Competitive, reversible inhibition of H1 receptors in PNS and CNS --> ↓ DAG/IP3}} [{{c2::1st Generation H1 Antagonist}}]
Extra
Lecture Notes
Missed Questions
Pathoma
Boards and Beyond
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Pixorize
Physeo
Bootcamp
OME
Additional Resources
One by one
ankihub_id
Suggested Changes:
Deck Changes (Suggestion to move the Note to the following Deck):
Field Changes:
Tag Changes: